Bausch Health Companies Inc.

Toronto Stock Exchange:BHC.TO

Sector

🛍 Consumer Discretionary

Industries

💄 Cosmetics

🔬 Clinical Trials

🕶 Eyewear

💊 Pharmaceuticals

🛍 Specialty Retail

Location

Canada

Market Cap

USD 2.28 B

Share Price

USD 6.16

Avg Daily Volume

372,844

Change (1 day)

2.70%

Change (1 year)

-8.46%

Change (YTD)

-23.67%

Bausch Health Companies Inc. Total Liabilities for the year ending December 31, 2024: USD 26.84 B

Bausch Health Companies Inc. Total Liabilities is USD 26.84 B for the year ending December 31, 2024, a -2.14% change year over year. Total liabilities are the total amount of a company's debts and other obligations.

Bausch Health Companies Inc. Total Liabilities for the year ending December 31, 2023 was USD 27.43 B, a 7.89% change year over year.
Bausch Health Companies Inc. Total Liabilities for the year ending December 31, 2022 was USD 25.43 B, a -13.03% change year over year.
Bausch Health Companies Inc. Total Liabilities for the year ending December 31, 2021 was USD 29.24 B, a -4.44% change year over year.
Bausch Health Companies Inc. Total Liabilities for the year ending December 31, 2020 was USD 30.59 B, a -6.52% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Total Liabilities	Shareholders' Equity	Cash and Short-Term Investments	Receivables

Toronto Stock Exchange: BHC.TO

Bausch Health Companies Inc.

CEO	Mr. Thomas J. Appio
IPO Date	April 3, 1996
Location	Canada
Headquarters	2150 St. ElzEar Boulevard West
Employees	20,700
Sector	🛍 Consumer Discretionary
Industries Cosmetics 🔬 Clinical Trials 🕶 Eyewear 💊 Pharmaceuticals 🛍 Specialty Retail

Description

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.